Identification of potent inhibitors of ATP synthase subunit c (AtpE) from Mycobacterium tuberculosis using in silico approach

被引:4
|
作者
Isa, Mustafa Alhaji [1 ]
Abubakar, Mustapha B. [2 ]
Mohammed, Mohammed Mustapha [1 ]
Ibrahim, Muhammad Musa [1 ]
Gubio, Falmata Audu [1 ]
机构
[1] Univ Maiduguri, Fac Sci, Dept Microbiol, PMB 1069, Maiduguri, Nigeria
[2] Univ Maiduguri, Fac Vet Med, Dept Vet Microbiol, Maiduguri, Nigeria
关键词
MTB; AtpE; ADME; Homology modeling; MD Simulation; EARLY BACTERICIDAL ACTIVITY; DRUG-RESISTANCE; TARGET; POLYPHENOLS; MUTATIONS; CHEMISTRY; DISCOVERY;
D O I
10.1016/j.heliyon.2021.e08482
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
ATP synthase subunit c (AtpE) is an enzyme that catalyzes the production of ATP from ADP in the presence of sodium or proton gradient from Mycobacterium tuberculosis (MTB). This enzyme considered an essential target for drug design and shares the same pathway with the target of Isoniazid. Thus, this enzyme would serve as an alternative target of the Isoniazid. The three dimensional (3D) model structure of the AtpE was constructed based on the principle of homology modeling using the Modeller9.16. The developed model was subjected to energy minimization and refinement using molecular dynamic (MD) simulation. The minimized model structure was searched against Zinc and PubChem database to determine ligands that bind to the enzyme with minimum binding energy using RASPD and PyRx tool. A total of 4776 compounds capable of bindings to AtpE with minimum binding energy were selected. These compounds further screened for physicochemical properties (Lipinski rule of five). All the compounds that possessed the desirable property selected and used for molecular docking analysis. Five (5) compounds with minimum binding energies ranged between-8.69, and-8.44 kcal/mol, less than the free binding energy of ATP were selected. These compounds further screened for the absorption, distribution, metabolism, excretion, and toxicity (ADME and toxicity) properties. Of the five compounds, three (ZINC14732869, ZINC14742188, and ZINC12205447) fitted all the ADME and toxicity properties and subjected to MD simulation and Molecular Mechanics Generalized Born and Surface Area (MM-GBSA) analyses. The results indicated that the ligands formed relatively stable complexes and had free binding energies, less than the binding energy of the ATP. Therefore, these ligands considered as prospective inhibitors of MTB after successful experimental validation.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Identification of potential inhibitors of shikimate kinase from Mycobacterium tuberculosis using in silico approach
    Mustafa Alhaji Isa
    Mohammed Mustapha Mohammed
    Muhammad Musa Ibrahim
    Falmata Audu Gubio
    Fatimah Buba
    Somia Shehzadi
    Journal of Proteins and Proteomics, 2024, 15 (2) : 159 - 173
  • [2] Structure based identification of novel inhibitors against ATP synthase of Mycobacterium tuberculosis: A combined in silico and in vitro study
    Shahbaaz, Mohd
    Cloete, Ruben
    Grobbelaar, Melanie
    Sampson, Samantha
    Christoffels, Alan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2019, 135 : 582 - 590
  • [3] Identification of natural potent inhibitors against Mycobacterium tuberculosis isocitrate lyase: an in silico study
    Rabaan, Ali A. A.
    Halwani, Muhammad A. A.
    Garout, Mohammed
    Turkistani, Safaa A. A.
    Alsubki, Roua A. A.
    Alawfi, Abdulsalam
    Alshengeti, Amer
    Najim, Mustafa A. A.
    Al Kaabi, Nawal A. A.
    Alqazih, Thikrayat Q. Q.
    Aseeri, Ali A. A.
    Bahitham, Afnan S. S.
    Alsubaie, Manal A. A.
    Alissa, Mohammed
    Aljeldah, Mohammed
    MOLECULAR DIVERSITY, 2024, 28 (05) : 2783 - 2799
  • [4] Identification and synthesis of novel inhibitors of mycobacterium ATP synthase
    Surase, Yogesh B.
    Samby, Kirandeep
    Amale, Sagar R.
    Sood, Ruchi
    Purnapatre, Kedar P.
    Pareek, Pawan K.
    Das, Biswajit
    Nanda, Kamna
    Kumar, Subodh
    Verma, Ashwani K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (15) : 3454 - 3459
  • [5] Mycobacterium tuberculosis F-ATP Synthase Inhibitors and Targets
    Harikishore, Amaravadhi
    Gruber, Gerhard
    ANTIBIOTICS-BASEL, 2024, 13 (12):
  • [6] Sulfonamide derivatives as Mycobacterium tuberculosis inhibitors: in silico approach
    Sayantan Pradhan
    Chittaranjan Sinha
    In Silico Pharmacology, 6 (1)
  • [7] Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase
    Baig, Irshad Ahmed
    Moon, Ji-Young
    Lee, Sang-Choon
    Ryoo, Sung-Weon
    Yoon, Moon-Young
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2015, 1854 (10): : 1338 - 1350
  • [8] Unraveling the possible inhibitors for Chorismate synthase to combat tuberculosis using in silico approach
    Hanif, Muhammad
    Khan, Sara
    Farooq, Umar
    Nouroz, Faisal
    Sarwar, Rizwana
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (07): : 2823 - 2830
  • [9] Identification of Potent ABL Inhibitors from Coumestrol: An Integrative In Silico Approach
    Raghi, Kottoly R.
    Sherin, Daisy R.
    Archana, Thottukara M.
    Saumya, Maria J.
    Sajesha, Karakkad P.
    Manojkumar, Thanathu K.
    JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2022, 21 (08): : 967 - 979
  • [10] ?Identification of alkaloid compounds as potent inhibitors of Mycobacterium tuberculosis NadD using computational strategies?
    Verma, Abhishek Kumar
    Dubey, Saumya
    Srivastava, Sandeep Kumar
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 158